🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Dylan J. Martini

Massachusetts General Hospital

ORCID: 0000-0002-0843-1222

Also affiliated with Dana-Farber Cancer Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors”.

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

Cancer Medicine(2020)10.1002/cam4.2932
N/A
0DataRank · unranked
18 citations

Dylan J. Martini, Yuan Liu, Deepak Ravindranathan, Jacqueline T. Brown, Emilie Elise Hitron +11 more

Curated multiple sequence alignment for the Adenomatous Polyposis Coli (APC) gene and accuracy of in silico pathogenicity predictions

PLoS ONE(2020)10.1371/journal.pone.0233673
N/A
0DataRank · unranked
3 citations

Dylan J. Martini, David J. Hermel, Dana Solcz, Marcy E. Richardson, Tina Pesaran +3 more

Association of modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (CPI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.738
N/A
0DataRank · unranked
1 citations

Yuan Liu, Dylan J. Martini, Julie M. Shabto, Elise Hitron, Greta Russler +11 more

Novel risk scoring system for metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (C).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.734
N/A
0DataRank · unranked
1 citations

Dylan J. Martini, Yuan Liu, Julie M. Shabto, Bradley Curtis Carthon, Elise Hitron +8 more

Association of baseline modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic urothelial cell carcinoma (mUCC) treated with immune checkpoint inhibitors (CPI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.563
N/A
0DataRank · unranked
1 citations

Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Elise Hitron +12 more

Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13868
N/A
0DataRank · unranked
43 citations

Subir Goyal, Yuan Liu, Sean T. Evans, T. Anders Olsen, Katherine Case +14 more

Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13922
N/A
0DataRank · unranked
32 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, T. Anders Olsen, Sean T. Evans +17 more

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002851
N/A
0DataRank · unranked
30 citations

Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Emilie Elise Hitron +13 more

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

Frontiers in Oncology(2021)10.3389/fonc.2021.701345
N/A
0DataRank · unranked
9 citations

Dylan J. Martini, Subir Goyal, Yuan Liu, Sean T. Evans, Benjamin Magod +12 more

Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib

Cancer Treatment and Research Communications(2021)10.1016/j.ctarc.2021.100393
N/A
0DataRank · unranked
4 citations

Meredith R. Kline, Yuan Liu, Julie M. Shabto, Bradley Curtis Carthon, Greta Russler +9 more

Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report

Journal of Medical Case Reports(2021)10.1186/s13256-020-02637-w
N/A
0DataRank · unranked
2 citations

Dylan J. Martini, Sean T. Evans, Jamie Goldman, Mehmet Asım Bilen, T. Anders Olsen

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The Oncologist(2022)10.1093/oncolo/oyac236
N/A
0DataRank · unranked
13 citations

Deepak Ravindranathan, Yuan Liu, Dylan J. Martini, Jacqueline T. Brown, Bassel Nazha +8 more

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

Journal of Immunotherapy and Precision Oncology(2022)10.36401/jipo-22-2
N/A
0DataRank · unranked
1 citations

T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Emilie Elise Hitron +12 more

Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors

The Oncologist(2023)10.1093/oncolo/oyad154
N/A
0DataRank · unranked
12 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, Dylan J. Martini, Bassel Nazha +13 more

Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes

American Journal of Clinical Pathology(2024)10.1093/ajcp/aqae161
N/A
0DataRank · unranked
5 citations

Dylan J. Martini, Melad Dababneh, Samuel Bidot, Bassel Nazha, Jacqueline T. Brown +7 more

PD‐L1 and nectin‐4 expression and genomic characterization of bladder cancer with divergent differentiation

Cancer(2024)10.1002/cncr.35465
N/A
0DataRank · unranked
6 citations

Katherine Case, Derrik Gratz, Kathryn L. Pellegrini, Elizabeth Beagle, Thomas M. Schneider +12 more